Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zarah Glad Zimling

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Histopathology|March 8, 2012
The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomasZarah Glad Zimling, Anne Jørgensen, Eric Santoni-Rugiu
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 17, 2007
Peripheral neuroblastic tumours in eastern Denmark 1972-2002Zarah Glad Zimling, Catherine Rechnitzer, Marianne Rasmussen, et al.
Anticancer Research|December 6, 2015
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural MesotheliomaZarah Glad Zimling, Eric Santoni-Rugiu, Cecilia Bech, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2011
Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survivalZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesotheliomaZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Cancer Research|April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastomaHeidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Histopathology|March 8, 2012
The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomasZarah Glad Zimling, Anne Jørgensen, Eric Santoni-Rugiu
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 17, 2007
Peripheral neuroblastic tumours in eastern Denmark 1972-2002Zarah Glad Zimling, Catherine Rechnitzer, Marianne Rasmussen, et al.
Anticancer Research|December 6, 2015
High RRM1 Expression Is Associated with Adverse Outcome in Patients with Cisplatin/Vinorelbine-treated Malignant Pleural MesotheliomaZarah Glad Zimling, Eric Santoni-Rugiu, Cecilia Bech, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2011
Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survivalZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesotheliomaZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Cancer Research|April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastomaHeidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Pageof 1